Rani Therapeutics Competitors and Similar CompaniesClear all
Rani Therapeutics's competitors and similar companies include Principia BioPharma, Oramed Pharmaceuticals, Athersys and Arbutus Biopharma.
 Rani Therapeutics Rani Therapeutics Holdings is a clinical-stage biotherapeutics company developing technologies for orally administered biologics. |  Principia BioPharma Principia Biopharma is a biopharmaceutical company offering oral therapies to immunology and oncology patients. |  Oramed Pharmaceuticals Oramed Pharmaceuticals is the developer of an innovative technology to transform injectable treatments into oral therapies. |  Athersys Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications. |  Arbutus Biopharma Arbutus Biopharma is a clinical-stage biopharmaceutical company that focuses on virology. | |
Founding Date | Founding Date 2012 | Founding Date 2008 | Founding Date 2006 | Founding Date 1995 | Founding Date 2005 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Jose, US HQ | Locations South San Francisco, US HQ | Locations New York, US HQ Jerusalem, IL | Locations Cleveland, US HQ Canton, US | Locations Warminster, US HQ |
Employees | Employees 71 | Employees 18 | Employees 1417% increase | Employees 8311% increase | Employees 1957% decrease |
Valuation ($) | Valuation ($) 135.4 m | Valuation ($) N/A | Valuation ($) 94.2 m | Valuation ($) 6.3 m | Valuation ($) 762.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $1.6m (FY, 2025) | Revenue (est.) $35.2m (FY, 2019) | Revenue (est.) $2m (FY, 2025) | Revenue (est.) $5.3m (FY, 2022) | Revenue (est.) $14.1m (FY, 2025) |
Net income | Net income ($41m) (FY, 2025) | Net income ($53.8m) (FY, 2019) | Net income $64m (FY, 2025) | Net income ($72.5m) (FY, 2022) | Net income ($33.5m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 176.5m | Total funding raised $ 89.9m | Total funding raised $ 1m | Total funding raised $ 9m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Principia BioPharma
HQ
South San Francisco, US
Principia Biopharma is a biopharmaceutical company offering oral therapies to immunology and oncology patients.
View companyOramed Pharmaceuticals
HQ
New York, US
Employees
14↑ 17% increase
Oramed Pharmaceuticals is the developer of an innovative technology to transform injectable treatments into oral therapies.
View companyAthersys
HQ
Cleveland, US
Employees
83↑ 11% increase
Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.
View companyArbutus Biopharma
HQ
Warminster, US
Employees
19
Arbutus Biopharma is a clinical-stage biopharmaceutical company that focuses on virology.
View company